Stock Research for cbis

cbis

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

cbis Stock Chart & Research Data

The cbis chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the cbis chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


cbis Due diligence Resources & Stock Charts

The cbis stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View cbis Detailed Price Forecast - CNN Money CNN View cbis Detailed Summary - Google Finance
Yahoo View cbis Detailed Summary - Yahoo! Finance Zacks View cbis Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View cbis Trends & Analysis - Trade-Ideas Barrons View cbis Major Holders - Barrons
NASDAQ View cbis Call Transcripts - NASDAQ Seeking View cbis Breaking News & Analysis - Seeking Alpha
Spotlight View cbis Annual Report - CompanySpotlight.com OTC Report View cbis OTC Short Report - OTCShortReport.com
TradeKing View cbis Fundamentals - TradeKing Charts View cbis SEC Filings - Bar Chart
WSJ View Historical Prices for cbis - The WSJ Morningstar View Performance/Total Return for cbis - Morningstar
MarketWatch View the Analyst Estimates for cbis - MarketWatch CNBC View the Earnings History for cbis - CNBC
StockMarketWatch View the cbis Earnings - StockMarketWatch MacroAxis View cbis Buy or Sell Recommendations - MacroAxis
Bullish View the cbis Bullish Patterns - American Bulls Short Pains View cbis Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View cbis Stock Mentions - StockTwits PennyStocks View cbis Stock Mentions - PennyStockTweets
Twitter View cbis Stock Mentions - Twitter Invest Hub View cbis Investment Forum News - Investor Hub
Yahoo View cbis Stock Mentions - Yahoo! Message Board Seeking Alpha View cbis Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for cbis - SECform4.com Insider Cow View Insider Transactions for cbis - Insider Cow
CNBC View cbis Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for cbis - OTC Markets
Yahoo View Insider Transactions for cbis - Yahoo! Finance NASDAQ View Institutional Holdings for cbis - NASDAQ


Stock Charts

FinViz View cbis Stock Insight & Charts - FinViz.com StockCharts View cbis Investment Charts - StockCharts.com
BarChart View cbis Stock Overview & Charts - BarChart Trading View View cbis User Generated Charts - Trading View




Latest Financial News for cbis


Cannabis Science Propels Cancer Clinical Trials, Appoints Cellular Cancer Specialist Dr. Sulma Mohammed, Professor of Cancer Biology, Purdue University, to the Company’s Scientific Advisory Board
Posted on Monday June 03, 2019

IRVINE, CA, June 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to announce the appointment of Dr. Sulma Mohammed, Professor of Cancer Biology at Purdue University, to the Company’s Scientific Advisory Board. Dr. Mohammed has extensive knowledge of molecular biology, cell biology, biochemistry, and microbiology, basic and applied medical sciences through her graduate programs at Cornell University and Purdue University, as well as experience in cancer research from the basic levels, to pre-clinical research in animal models, through to human clinical trials.


GHC Summit at Harvard Medical School Announces Cannabis Science as Industry Partner in the Launch of the International Phytomedicines Institute at Harvard Medical School
Posted on Friday May 31, 2019

IRVINE, CA, May 31, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the research and development of cannabinoid-based medicines, is proud to announce it has been introduced as one of the key industry partners in the recently launched, ground-breaking International Phytomedicines Institute (IPI) at Harvard Medical School. The International Phytomedicines Institute (IPI), launched during this year’s Harvard GHC Summit, is a transformative initiative by the Global Health Catalyst designed to elevate phytomedicines in global health, accelerate clinical translation and commercialization of evidence-based plant medicines/healthcare products and provide a world class core facility for research, and consultation on medicinal plants.


What Kind Of Shareholders Own Cannabis One Holdings Inc. (CNSX:CBIS)?
Posted on Monday May 27, 2019

The big shareholder groups in Cannabis One Holdings Inc. (CNSX:CBIS) have power over the company. Institutions often...


Cannabis Science Set to Participate in the Premier Event Focused on High-Impact Global Collaborations; The Global Health Catalyst Summit at Harvard Medical School Starts Today
Posted on Friday May 24, 2019

IRVINE, CA, May 24, 2019 -- via NEWMEDIAWIRE -- Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabinoid-based medicines, is pleased to.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.